外周血管畸形的结局测量工具及其测量特性评估：系统评价。
Outcome measurement instruments for peripheral vascular malformations and an assessment of the measurement properties: a systematic review.
机构信息
Department of Plastic, Reconstructive and Hand Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Qual Life Res. 2020 Jan;29(1):1-17. doi: 10.1007/s11136-019-02301-x. Epub 2019 Sep 23.
PURPOSE
The Outcome measures for vascular malformation (OVAMA) group reached consensus on the core outcome domains for the core outcome set (COS) for peripheral vascular malformations (venous, lymphatic and arteriovenous malformations). However, it is unclear which instruments should be used to measure these domains. Therefore, our aims were to identify all outcome measurement instruments available for vascular malformations, and to evaluate their measurement properties.
METHODS
With the first literature search, we identified outcomes and instruments previously used in prospective studies on vascular malformations. A second search yielded studies on measurement properties of patient- and physician-reported instruments that were either developed for vascular malformations, or used in prospective studies. If the latter instruments were not specifically validated for vascular malformations, we performed a third search for studies on measurement properties in clinically similar diseases (vascular or lymphatic diseases and benign tumors). We assessed the methodological quality of these studies following the Consensus-based Standards for the selection of health Measurement Instruments methodology, and evaluated the quality of the measurement properties.
RESULTS
The first search yielded 27 studies, none using disease-specific instruments. The second and third search included 22 development and/or validation studies, concerning six instruments. Only the Lymphatic Malformation Function Instrument was developed specifically for vascular malformations. Other instruments were generic QoL instruments developed and/or partly validated for clinically similar diseases.
CONCLUSIONS
Additional research on measurement properties is needed to assess which instruments may be included in the COS. This review informs the instrument selection and/or the development of new instruments.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO, 42017056242.
目的
血管畸形结局测量（OVAMA）小组就外周血管畸形（静脉、淋巴和动静脉畸形）的核心结局集（COS）的核心结局域达成了共识。然而，目前尚不清楚应该使用哪些工具来衡量这些领域。因此，我们的目的是确定可用于血管畸形的所有结局测量工具，并评估其测量特性。
方法
通过第一次文献检索，我们确定了先前在血管畸形前瞻性研究中使用的结局和工具。第二次检索则获得了关于患者和医生报告的工具的测量特性的研究，这些工具要么是为血管畸形开发的，要么是在前瞻性研究中使用的。如果这些工具不是专门针对血管畸形进行验证的，我们会进行第三次搜索，以寻找在临床相似疾病（血管或淋巴疾病和良性肿瘤）中测量特性的研究。我们根据基于共识的健康测量仪器选择标准来评估这些研究的方法学质量，并评估测量特性的质量。
结果
第一次搜索产生了 27 项研究，均未使用疾病特异性工具。第二次和第三次搜索包括 22 项开发和/或验证研究，涉及 6 种工具。只有淋巴畸形功能仪器是专门为血管畸形开发的。其他工具是为临床相似疾病开发和/或部分验证的通用 QoL 工具。
结论
需要进一步研究测量特性，以评估哪些工具可能被纳入 COS。本综述为工具选择和/或新工具的开发提供了信息。
系统评价注册
PROSPERO，42017056242。
Zotero 插件